Crotonaldehyde accumulates in glial cells of Alzheimer's disease brain

被引:48
|
作者
Kawaguchi-Niida, M
Shibata, N
Morikawa, S
Uchida, K
Yamamoto, T
Sawada, T
Kobayashi, M
机构
[1] Tokyo Womens Med Univ, Dept Surg Pathol, Shinjuku Ku, Tokyo 1628666, Japan
[2] Tokyo Womens Med Univ, Dept Pathol, Shinjuku Ku, Tokyo 1628666, Japan
[3] Tokyo Womens Med Univ, Dept Anat & Dev Biol, Shinjuku Ku, Tokyo 1628666, Japan
[4] Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi, Japan
关键词
Alzheimer's disease; astrocyte; crotonaldehyde; lipid peroxidation; microglia;
D O I
10.1007/s00401-006-0044-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Several studies have documented the involvement of oxidative stress represented by lipid peroxidation in the pathogenesis of Alzheimer's disease (AD). To test whether the highly reactive carbonyl crotonaldehyde (CRA), generated during lipid peroxidation, is involved in AD, we performed an immunohistochemical analysis in AD and age-matched control hippocampi using a specific antibody against protein-bound CRA (P-CRA). In the AD cases, P-CRA immunoreactivity was preferentially localized in reactive astrocytes and microglia around senile plaques (SPs) and those present in the neuropil, while it was weakly detectable in neurons and neurofibrillary tangles. P-CRA immunoreactivity was also localized in all portions of diffuse SPs and the dystrophic neurites of neuritic and classical SPs, but was undetectable in amyloid cores. Age-matched controls showed P-CRA immunoreactivity only very weakly in neurons. In contrast to P-CRA, immunoreactivities for protein-bound acrolein and 4-hydroxy-2-nonenal were mainly localized to neurons and rarely seen in glial cells. Our results suggest that increased oxidative stress and CRA formation in glial cells is implicated in the disease processes of AD.
引用
收藏
页码:422 / 429
页数:8
相关论文
共 50 条
  • [31] Glial cells in Alzheimer?s disease: From neuropathological changes to therapeutic implications
    Lim, Lee Wei
    Uddin, Md . Sahab
    AGEING RESEARCH REVIEWS, 2022, 78
  • [32] The number of neurons and glial cells in the inferior olivary nucleus in Alzheimer's disease
    Bogdanovic, N
    Lasn, H
    BRAIN PATHOLOGY, 2000, 10 (04) : 514 - 515
  • [33] Applying of extracellular vesicles of glial progenitor cells for the treatment of Alzheimer's disease
    Shedenkova, Margarita
    Belousova, Ekaterina
    Salikhova, Diana
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [34] Analyzing the glial proteome in Alzheimer's disease
    Kim, Jong-Heon
    Afridi, Ruqayya
    Lee, Won-Ha
    Suk, Kyoungho
    EXPERT REVIEW OF PROTEOMICS, 2023, 20 (10) : 197 - 209
  • [35] "Glial inhibition" of memory in Alzheimer's disease
    Yuan Ti-Fei
    Shan Chunlei
    SCIENCE CHINA-LIFE SCIENCES, 2014, 57 (12) : 1238 - 1240
  • [36] In Vivo Direct Reprogramming of Reactive Glial Cells into Functional Neurons after Brain Injury and in an Alzheimer's Disease Model
    Guo, Ziyuan
    Zhang, Lei
    Wu, Zheng
    Chen, Yuchen
    Wang, Fan
    Chen, Gong
    CELL STEM CELL, 2014, 14 (02) : 188 - 202
  • [37] Alterations of the blood-brain barrier and glial cells in white matter lesions in cerebrovascular and Alzheimer's disease patients
    Leys, D
    Henon, H
    Pasquier, F
    STROKE, 1997, 28 (04) : 874 - 875
  • [38] Glial Reaction of the Subventricular Zone of the Telencephalon of the Rat Brain on Modeling of Alzheimer’s Disease
    E. I. Chumasov
    D. E. Korzhevskii
    E. S. Petrova
    N. N. Kuznetsova
    N. S. Sapronov
    Neuroscience and Behavioral Physiology, 2012, 42 (1) : 67 - 71
  • [39] Proteomic analysis of glial fibrillary acidic protein in Alzheimer's disease and aging brain
    Korolainen, MA
    Auriola, S
    Nyman, TA
    Alafuzoff, I
    Pirttilä, T
    NEUROBIOLOGY OF DISEASE, 2005, 20 (03) : 858 - 870
  • [40] The muscle protein dysferlin accumulates in the Alzheimer brain
    Galvin, James E.
    Palamand, Divya
    Strider, Jev
    Milone, Margherita
    Pestronk, Alan
    ACTA NEUROPATHOLOGICA, 2006, 112 (06) : 665 - 671